InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Friday, 12/23/2022 2:22:52 PM

Friday, December 23, 2022 2:22:52 PM

Post# of 425926
We need more information about any Amarin plans for MND-2119...Thus far, management has been giving out vague minimal details on the subject, even as Mochida has already begun marketing this more convenient and more cost effective new form of EPA in Japan.

Vascepa has stalled in both the U.S. and in Europe...Its time for a new approach.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News